(Q51141745)

30 March 2018

title

The impact of generalized malignant melanoma on quality of life evaluated by the EORTC questionnaire technique. (English)

1 reference

30 March 2018

1 reference

1 reference

V Sigurdardóttir

1

1 reference

30 March 2018

C Bolund

series ordinal

2

1 reference

30 March 2018

Y Brandberg

series ordinal

3

1 reference

30 March 2018

M Sullivan

series ordinal

4

1 reference

30 March 2018

publication date

1 June 1993

1 reference

30 March 2018

published in

Quality of Life Research

1 reference

30 March 2018

volume

2

1 reference

30 March 2018

issue

3

1 reference

30 March 2018

page(s)

193-203

1 reference

30 March 2018

https://scigraph.springernature.com/pub.10.1007/bf00435223

exact match

0 references

cites work

Living with melanoma: content analysis of interviews.

1 reference

12 December 2020

Trends in survival from malignant melanoma: remarkable improvement in 23 years

1 reference

12 December 2020

The relationship of psychological distress, extent of disease, and performance status in patients with lung cancer.

1 reference

12 December 2020

Trends in malignant melanoma of the skin.

1 reference

12 December 2020

Quality of life research in oncology. Past achievements and future priorities

1 reference

12 December 2020

Comparative studies of psychological function in patients with advanced cancer. II. Interviewer-rated current and past psychological symptoms.

1 reference

12 December 2020

Quality of Life During Chemotherapy for Small Cell Lung Cancer: II. A longitudinal study of the EORTC Core Quality of Life Questionnaire and comparison with the Sickness Impact Profile

1 reference

12 December 2020

Convergent and discriminant validation by the multitrait-multimethod matrix.

1 reference

12 December 2020

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

12 December 2020

Measuring quality of life today: methodological aspects.

1 reference

12 December 2020

The hospital anxiety and depression scale

1 reference

12 December 2020

Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires

1 reference

12 December 2020

Disseminated melanoma--is there a new standard therapy?

1 reference

12 December 2020

Toxicity, physical function and everyday activity reported by patients with inoperable non-small cell lung cancer in a randomized trial (chemotherapy versus radiotherapy)

1 reference

12 December 2020

Integration of chemotherapy into combined modality therapy of solid tumors. IV. Malignant melanoma

1 reference

12 December 2020

Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefit

1 reference

12 December 2020

The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer.

1 reference

12 December 2020

Spinal cord injuries. Clinical, functional, and emotional status

1 reference

12 December 2020

Dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A phase I-II trial

1 reference

12 December 2020

Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen

1 reference

12 December 2020

Quality of life during chemotherapy for small cell lung cancer. I. An evaluation with generic health measures.

1 reference

12 December 2020

The quality of life of cancer patients: a review of the literature

1 reference

12 December 2020

Dacarbazine versus dacarbazine-vindesine in disseminated malignant melanoma: a randomized phase II study

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00435223

1 reference

30 March 2018

1 reference

30 March 2018